Pharma & Biotech
You will receive alerts when there are new announcements on Kazia Therapeutics Ltd
Only registered members can use this feature.
Kazia Therapeutics (ASX: KZA, NASDAQ: KZIA) pipeline includes two clinical-stage drug development candidates.
The biotech has delivered all milestones to date, with multiple data read-outs expected over 6-12 months.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.